Hydrophobicity parameters determined by reversed-phase liquid chromatography. XVI: A new hydrogen-accepting parameter for monosubstituted thiophenes and furans for correlating retention factors and octanol-water partition coefficients

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 10, 2003, Pages 1196-1200

  Yamagami, Chisako ^a   Tachikawa, Hiromi ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Conductor like screening model (cosmo); Furan; Hydrogen accepting parameter; Partition coefficient; Retention factor; Thiophene

Indexed keywords

FURAN; OCTANOL; THIOPHENE; WATER; FURAN DERIVATIVE; HYDROGEN; THIOPHENE DERIVATIVE;

ARTICLE; CORRELATION ANALYSIS; ELUTION; HYDROGEN BOND; HYDROPHOBICITY; MATHEMATICAL ANALYSIS; PH MEASUREMENT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SUBSTITUTION REACTION; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FURANS; HYDROGEN; HYDROGEN BONDING; HYDROPHOBICITY; OCTANOLS; THIOPHENES;

EID: 2442602369     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.1196     Document Type: Article

References (30)

1. A part of this work was based on a lecture presented at LogP2000-The Second Lipophilicity Symposium, University of Lausanne, Lausanne, on 8 March 2000.
2. Hansch C., Hoekman D., Gao H., Chem. Rev., 96, 1045-1076 (1996).
3. Testa B., van de Waterbeemd H., Folkers G., Guy R., "Pharmacokinetic Optimization in Drug Research," Wiley-VCH, Weinheim, 2001.
4. Fujita T., Prog. Phys. Org. Chem., 14, 75-113 (1983).
5. Leo A., Chem. Rev., 93, 1281-1306 (1993).
6. Chuman H., Mori A., Tanaka H., Anal. Sci., 18, 1015-1020 (2002).
7. Zou J.-W., Zhao W.-N., Shang Z.-C., Huang M.-L., Guo M., Yu Q.-S., J. Phys. Chem., 106, 11550-11557 (2002).
8. Braumann T., J. Chromatogr., 373, 191-225 (1986).
9. Terada H., Quant. Struct.-Act. Relat., 5, 81-88 (1986).
10. Minick D. J., Frenz J. H., Patrick M. A., Brent D. A., J. Med. Chem., 31, 1923-1933 (1988).
11. Lambert W. J., J. Chromatogr. A., 656, 469-484 (1993).
12. Herbert B. J., Dorsey J. G., Anal. Chem., 67, 744-749 (1995).
13. Fujita T., Nishioka T., Nakajima M., J. Med. Chem., 20, 1071-1081 (1977).
14. Yamagami C., "Pharmacokinetic Optimization in Drug Research," Wiley-VCH, Weinheim, 2001, pp. 383-400.
15. Yamagami C., Ogura T., Takao N., J. Chromatogr., 514, 123-136 (1990).
16. Yamagami C., Takao N., Chem. Pharm. Bull., 40, 925-929 (1992).
17. Yamagami C., Yokota M., Takao N., J. Chromatogr. A, 662, 49-60 (1994).
18. Yamagami C., Yokota M., Takao N., Chem Pharm Bull., 42, 907-912 (1994).
19. Yamagami C., Masaki Y., Chem. Pharm. Bull., 43, 2238-2242 (1995).
20. Yamagami C., Takao N., Fujita T., J. Pharm. Sci., 82, 155-161 (1993).
21. Yamagami C., Kawase K., Fujita T., Quant. Struct.-Act. Relat., 18, 26-34 (1999).
22. Klamt A., Shüürmann G., J. Chem. Soc., Perkin Trans. 2, 1993, 799-805 (1993).
23. Charton M., Prog. Phys. Org. Chem., 13, 119-251 (1981).
24. Abraham M. H., Grellier P. L., Prior D. V., Duce P. P., Morris J. J., Taylor P. J., J. Chem. Soc., Perkin Trans. 2, 1989, 699-711 (1989).
25. Abraham M. H., J. Phys. Org. Chem., 6, 660-684 (1993).
26. Abraham M. H., Chadha H. S., Leo A. J., J. Chromatogr. A, 685, 203-211 (1994).
27. Lewis S. J., Mirrlees M. S., Taylor P. J., Quant. Struct.-Act. Relat., 2, 100-111 (1983).
28. Yamagami C., Takao N., Chem. Pharm. Bull., 41, 694-698 (1993).
29. Dewar M. J. S., Zoebisch E. G., Healy E. F., Stewart J. J. P., J. Am. Chem. Soc., 107, 3902-3909 (1985).
30. Stewart J. J. P., Fujitsu Ltd., 1993, Tokyo.